98-7492. Titanium Dioxide; Exemption from the Requirement of a Tolerance  

  • [Federal Register Volume 63, Number 57 (Wednesday, March 25, 1998)]
    [Rules and Regulations]
    [Pages 14360-14363]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-7492]
    
    
    -----------------------------------------------------------------------
    
    ENVIRONMENTAL PROTECTION AGENCY
    
    40 CFR Part 180
    
    [OPP-300632; FRL-5779-3]
    RIN 2070-AB78
    
    
    Titanium Dioxide; Exemption from the Requirement of a Tolerance
    
    AGENCY: Environmental Protection Agency (EPA).
    
    ACTION: Final rule.
    
    -----------------------------------------------------------------------
    
    SUMMARY: This regulation establishes an exemption from the requirement 
    of a tolerance for residues of titanium dioxide when used as an inert 
    ingredient (UV protectant) in microencapsulated formulations of lambda-
    cyhalothrin. Zeneca AgProducts requested this tolerance exemption under 
    the Federal Food, Drug and Cosmetic Act (FFDCA), as amended by the Food 
    Quality Protection Act of 1996 (Pub. L. 104-170).
    
    DATES: This regulation is effective March 25, 1998. Objections and 
    requests for hearings must be received by EPA on or before April 24, 
    1998.
    
    [[Page 14361]]
    
    ADDRESSES: Written objections and hearing requests, identified by the 
    docket control number, [OPP-300632], must be submitted to: Hearing 
    Clerk (1900), Environmental Protection Agency, Rm. M3708, 401 M St., 
    SW., Washington, DC 20460. Fees accompanying objections and hearing 
    requests shall be labeled ``Tolerance Petition Fees'' and forwarded to: 
    EPA Headquarters Accounting Operations Branch, OPP (Tolerance Fees), 
    P.O. Box 360277M, Pittsburgh, PA 15251. A copy of any objections and 
    hearing requests filed with the Hearing Clerk identified by the docket 
    control number, [OPP-300632], must also be submitted to: Public 
    Information and Records Integrity Branch, Information Resources and 
    Services Division (7502C), Office of Pesticide Programs, Environmental 
    Protection Agency, 401 M St., SW., Washington, DC 20460. In person, 
    bring a copy of objections and hearing requests to Rm. 119, CM 1B2, 
    1921 Jefferson Davis Hwy., Arlington, VA.
        A copy of objections and hearing requests filed with the Hearing 
    Clerk may also be submitted electronically by sending electronic mail 
    (e-mail) to: opp-docket@epamail.epa.gov. Copies of objections and 
    hearing requests must be submitted as an ASCII file avoiding the use of 
    special characters and any form of encryption. Copies of objections and 
    hearing requests will also be accepted on disks in WordPerfect 5.1/6.1 
    file format or ASCII file format. All copies of objections and hearing 
    requests in electronic form must be identified by the docket control 
    number [OPP-300632]. No Confidential Business Information (CBI) should 
    be submitted through e-mail. Electronic copies of objections and 
    hearing requests on this rule may be filed online at many Federal 
    Depository Libraries.
    
    FOR FURTHER INFORMATION CONTACT: By mail: Indira Gairola, Registration 
    Division (7505W), Office of Pesticide Programs, Environmental 
    Protection Agency, 401 M St., SW., Washington, DC 20460. Office 
    location, telephone number, and e-mail address: 4th Floor, Crystal 
    Station 1B1, 2800 Crystal Drive,, Arlington, VA, 22202, (703)-308-8371, 
    e-mail: gairola.indira@epamail.epa.gov.
    
    SUPPLEMENTARY INFORMATION: In the Federal Register of June 20, 1997 (62 
    FR 33641) (FRL-5723-7), EPA issued a notice pursuant to section 408 of 
    the Federal Food, Drug, and Cosmetic Act (FFDCA), 21 U.S.C. 346a(e) 
    announcing the filing of a pesticide petition (PP 6E4675) for a 
    tolerance exemption by Zeneca Ag. Products, 1800 Concord Pike, P.O Box 
    15458, Wilmington, DE 19850-5458. This notice included a summary of the 
    petition prepared by Zeneca Ag. Products, the petitioner. There were no 
    comments received in response to the notice of filing.
        The petition requested that 40 CFR 180.1001 (d) be amended by 
    establishing an exemption from the requirement of a tolerance for 
    residues of the inert ingredient titanium dioxide, when used as an 
    inert ingredient (UV protectant) in microencapsulated formulations of 
    lambda-cyhalothrin applied to growing crops.
    
    I. Risk Assessment and Statutory Findings
    
        New section 408(b)(2)(A)(i) of the FFDCA allows EPA to establish a 
    tolerance (the legal limit for a pesticide chemical residue in or on a 
    food) only if EPA determines that the tolerance is ``safe.'' Section 
    408(b)(2)(A)(ii) defines ``safe'' to mean that ``there is a reasonable 
    certainty that no harm will result from aggregate exposure to the 
    pesticide chemical residue, including all anticipated dietary exposures 
    and all other exposures for which there is reliable information.'' This 
    includes exposure through drinking water and in residential settings, 
    but does not include occupational exposure. Section 408(b)(2)(C) 
    requires EPA to give special consideration to exposure of infants and 
    children to the pesticide chemical residue in establishing a tolerance 
    and to ``ensure that there is a reasonable certainty that no harm will 
    result to infants and children from aggregate exposure to the pesticide 
    chemical residue. . . .''
        EPA performs a number of analyses to determine the risks from 
    aggregate exposure to pesticide residues. First, EPA determines the 
    toxicity of pesticides based primarily on toxicological studies using 
    laboratory animals. These studies address many adverse health effects, 
    including (but not limited to) reproductive effects, developmental 
    toxicity, toxicity to the nervous system, and carcinogenicity. Second, 
    EPA examines exposure to the pesticide through the diet (e.g., food and 
    drinking water) and through exposures that occur as a result of 
    pesticide use in residential settings.
    
    II. Aggregate Risk Assessment and Determination of Safety
    
        Consistent with section 408(b)(2)(D), EPA has reviewed the 
    available scientific data and other relevant information in support of 
    this action, EPA has sufficient data to assess the hazards of titanium 
    dioxide and to make a determination on aggregate exposure, consistent 
    with section 408(b)(2), an exemption from the requirement of a 
    tolerance for residues of titanium dioxide when used as an inert 
    ingredient (UV protectant) in microencapsulated formulations of lambda-
    cyhalothrin. EPA's assessment of the dietary exposures and risks 
    associated with establishing the tolerance follows.
    
    A. Toxicological Profile
    
        Titanium is the eighth most abundant element in the earth's crust 
    and consequently spontaneously enters the food chain to some degree. 
    Titanium dioxide (TiO2) is a major constituent of a number of minerals, 
    including rutile, which consists of 95% titanium dioxide. The most 
    commercially important of the titanium compounds, titanium dioxide 
    annual worldwide production is estimated to be appoximately two million 
    metric tons. Titanium dioxide is an opaque powder that is approved for 
    use as a colorant in food (21 CFR 73.575), in drugs (21 CFR 73.1575), 
    and in cosmetics (21 CFR 73.2575; 21 CFR 73.3126). It has an extensive 
    range of industrial uses (e.g., paint, paper, and plastics). Titanium 
    dioxide is currently exempt from the requirement for a tolerance when 
    used as a colorant in pesticide formulations (40 CFR 180.1001(d)).
        A National Cancer Institute bioassay concluded that titanium 
    dioxide did not affect mortality, and was not carcinogenic at dose 
    levels of 25,000 or 50,000 ppm in rats or mice.
        The World Health Organization Committee on Food Coloring Materials 
    has determined that no ADI need be set for the use of titanium dioxide 
    based on the range of acute, subacute and chronic toxicity assays, all 
    showing low mammalian toxicity, including a two year chronic feeding 
    study in mice which was negative for carcinogenicity. Indeed, titanium 
    dioxide is frequently used as a negative control material in in vivo 
    chronic dust exposure studies and in in vivo assessments of fibrogenic 
    potential of dusts.
    
    B. Exposures and Risks
    
        Titanium dioxide is currently approved for use in a significant 
    number of pharmaceutical, cosmetic, industrial and food products. 
    Therefore, the potential for aggregate exposure from dietary and non-
    dietary routes does exist for titanium dioxide. While it is difficult 
    to develop a precise estimate of total human exposure to titanium 
    dioxide, its low toxicity at relatively high doses indicate that 
    current exposures are likely to be significantly below levels that may 
    result in adverse health effects. Titanium dioxide is approved for use 
    in food generally up to
    
    [[Page 14362]]
    
    1% of the final weight of the food (10,000 ppm). Even the most extreme 
    assumptions regarding its presence in foods following use as an inert 
    ingredient in lambda-cyhalothrin formulations would not result in a 
    measurable increase in potential dietary intake of titanium dioxide.
        All registered lambda-cyhalothrin products to which titanium 
    dioxide is added as an inert ingredient are commercial agricultural 
    products not registered for residential use. The potential for non-
    occupational exposures by the general population above current 
    background levels resulting from the many non-pesticidal uses of 
    titanium dioxide is unlikely.
        Section 408(c)(2)(B) requires that, when considering whether to 
    establish, modify, or revoke an exemption from the requirement of a 
    tolerance, the Agency consider ``available information'' concerning the 
    cumulative effects of a particular pesticide chemical's residues and 
    ``other substances that have a common mechanism of toxicity.'' The 
    Agency believes that ``available information'' in this context might 
    include not only toxicity, chemistry, and exposure data, but also 
    scientific policies and methodologies for understanding common 
    mechanisms of toxicity and conducting cumulative risk assessments. For 
    most pesticide chemicals, although the Agency has some information in 
    its files that may turn out to be helpful in eventually determining 
    whether a pesticide shares a common mechanism of toxicity with any 
    other substances, EPA does not at this time have the methodologies to 
    resolve the complex scientific issues concerning common mechanism of 
    toxicity in a meaningful way. EPA has begun a pilot process to study 
    this issue further through the examination of particular classes of 
    pesticides. The Agency hopes that the results of this pilot process 
    will increase the Agency's scientific understanding of this question 
    such that EPA will be able to develop and apply scientific principles 
    for better determining which chemicals have a common mechanism of 
    toxicity and evaluating the cumulative effects of such chemicals. The 
    Agency anticipates, however, that even as its understanding of the 
    science of common mechanisms increases, decisions on specific classes 
    of chemicals will be heavily dependent on chemical specific data, much 
    of which may not be presently available.
        Although at present the Agency does not know how to apply the 
    information in its files concerning common mechanism issues to most 
    risk assessments, there are pesticides as to which the common mechanism 
    issues can be resolved. These pesticides include pesticides that are 
    toxicologically dissimilar to existing chemical substances (in which 
    case the Agency can conclude that it is unlikely that a pesticide 
    shares a common mechanism of activity with other substances) and 
    pesticides that produce a common toxic metabolite (in which case common 
    mechanism of activity will be assumed).
        EPA does not have, at this time, available data to determine 
    whether titanium dioxide has a common mechanism of toxicity with other 
    substances or how to include this pesticide chemical in a cumulative 
    risk assessment. Unlike other pesticide chemicals for which EPA has 
    followed a cumulative risk approach based on a common mechanism of 
    toxicity, titanium dioxide does not appear to produce a toxic 
    metabolite produced by other substances. For the purposes of this 
    tolerance action, therefore, EPA has not assumed that titanium dioxide 
    has a common mechanism of toxicity with other substances.
    
    C. Aggregate Risks and Determination of Safety for U.S. Population, 
    Infants and Children
    
        Based on its low toxicity, there is reasonable certainty that no 
    harm will result from aggregate exposure to the U.S. population, 
    including infants and children, to residues of titanium dioxide. This 
    includes all anticipated dietary exposures and all other exposures for 
    which there is reliable information. The Agency has arrived at this 
    conclusion because of the inconsequential increases in dietary exposure 
    resulting from its application to growing crops as an inert ingredient 
    in formulations of lambda-cyhalothrin.
        FFDCA section 408 provides that EPA shall apply an additional 
    tenfold margin of safety for infants and children in the case of 
    threshold effects in calculating a dose level that to account for pre-
    and post-natal toxicity and the completeness of the database unless EPA 
    determines that a different margin of safety will be safe for infants 
    and children. Margins of safety are incorporated into EPA risk 
    assessments either directly through the use of margin of exposure 
    analysis or through using uncertainty (safety) in calculating a dose 
    level that poses no appreciable risk to humans.
        Due to low toxicity of titanium dioxide, EPA has not used a safety 
    factor analysis in assessing the risk of this compound. For the same 
    reason, application of the additional safety factor for infants and 
    children would not be appropriate.
    
    III. Other Considerations
    
    A. Analytical Enforcement Methodology
    
         The Agency is establishing an exemption from the requirement of a 
    tolerance without any numerical limitation; therefore, the Agency has 
    concluded that an analytical method is not required for enforcement 
    purposes for titanium dioxide.
    
    B. International Residue Limits
    
        No Codex maximum residue levels have been established for titanium 
    dioxide.
    
    IV. Conclusion
    
        Therefore, an exemption from the requirement of a tolerance is 
    established for residues of titanium dioxide when used as an inert 
    ingredient (UV protectant) in microencapsulated formulations of lambda-
    cyhalothrin at no more than 3% by weight of the formulation.
    
    V. Objections and Hearing Requests
    
        The new FFDCA section 408(g) provides essentially the same process 
    for persons to ``object'' to a tolerance regulation issued by EPA under 
    new section 408(e) and (l)(6) as was provided in the old section 408 
    and in section 409. However, the period for filing objections is 60 
    days, rather than 30 days. EPA currently has procedural regulations 
    which govern the submission of objections and hearing requests. These 
    regulations will require some modification to reflect the new law. 
    However, until those modifications can be made, EPA will continue to 
    use those procedural regulations with appropriate adjustments to 
    reflect the new law.
        Any person may, by May 26, 1998, file written objections to any 
    aspect of this regulation and may also request a hearing on those 
    objections. Objections and hearing requests must be filed with the 
    Hearing Clerk, at the address given above (40 CFR 178.20). A copy of 
    the objections and/or hearing requests filed with the Hearing Clerk 
    should be submitted to the OPP docket for this rulemaking. The 
    objections submitted must specify the provisions of the regulation 
    deemed objectionable and the grounds for the objections (40 CFR 
    178.25). Each objection must be accompanied by the fee prescribed by 40 
    CFR 180.33(i). If a hearing is requested, the objections must include a 
    statement of the factual issues on which a hearing is requested, the 
    requestor's contentions on such issues, and a summary of any evidence 
    relied upon by the requestor (40 CFR 178.27). A request for a hearing 
    will be granted if
    
    [[Page 14363]]
    
    the Administrator determines that the material submitted shows the 
    following: There is genuine and substantial issue of fact; there is a 
    reasonable possibility that available evidence identified by the 
    requestor would, if established, resolve one or more of such issues in 
    favor of the requestor, taking into account uncontested claims or facts 
    to the contrary; and resolution of the factual issues in the manner 
    sought by the requestor would be adequate to justify the action 
    requested (40 CFR 178.32). Information submitted in connection with an 
    objection or hearing request may be claimed confidential by marking any 
    part or all of that information as CBI. Information so marked will not 
    be disclosed except in accordance with procedures set forth in 40 CFR 
    part 2. A copy of the information that does not contain CBI must be 
    submitted for inclusion in the public record. Information not marked 
    confidential may be disclosed publicly by EPA without prior notice.
    
    VI. Public Docket
    
        EPA has established a record for this rulemaking under docket 
    control number [OPP-300632] (including any comments and data submitted 
    electronically). A public version of this record, including printed, 
    paper versions of electronic comments, which does not include any 
    information claimed as CBI, is available for inspection from 8:30 a.m. 
    to 4 p.m., Monday through Friday, excluding legal holidays. The public 
    record is located in Room 119 of the Public Information and Records 
    Integrity Branch, Information Resources and Services Division (7502C), 
    Office of Pesticide Programs, Environmental Protection Agency, Crystal 
    Mall 1B2, 1921 Jefferson Davis Hwy., Arlington, VA.
        Electronic comments may be sent directly to EPA at:
        opp-docket@epamail.epa.gov.
    
    
        Electronic comments must be submitted as an ASCII file avoiding the 
    use of special characters and any form of encryption.
        The official record for this rulemaking, as well as the public 
    version, as described above will be kept in paper form. Accordingly, 
    EPA will transfer any copies of objections and hearing requests 
    received electronically into printed, paper form as they are received 
    and will place the paper copies in the official rulemaking record which 
    will also include all comments submitted directly in writing. The 
    official rulemaking record is the paper record maintained at the 
    Virginia address in ``ADDRESSES'' at the beginning of this document.
    
    VII. Regulatory Assessment Requirements
    
        This final rule establishes an exemption from the requirement of a 
    tolerance under FFDCA section 408(d) in response to a petition 
    submitted to the Agency. The Office of Management and Budget (OMB) has 
    exempted these types of actions from review under Executive Order 
    12866, entitled Regulatory Planning and Review (58 FR 51735, October 4, 
    1993). This final rule does not contain any information collections 
    subject to OMB approval under the Paperwork Reduction Act (PRA), 44 
    U.S.C. 3501 et seq., or impose any enforceable duty or contain any 
    unfunded mandate as described under Title II of the Unfunded Mandates 
    Reform Act of 1995 (UMRA) (Pub. L. 104-4). Nor does it require any 
    prior consultation as specified by Executive Order 12875, entitled 
    Enhancing the Intergovernmental Partnership (58 FR 58093, October 28, 
    1993), or special considerations as required by Executive Order 12898, 
    entitled Federal Actions to Address Environmental Justice in Minority 
    Populations and Low-Income Populations (59 FR 7629, February 16, 1994), 
    or require OMB review in accordance with Executive Order 13045, 
    entitled Protection of Children from Environmental Health Risks and 
    Safety Risks (62 FR 19885, April 23, 1997).
        In addition, since these tolerances and exemptions that are 
    established on the basis of a petition under FFDCA section 408(d), such 
    as the tolerance exemption in this final rule, do not require the 
    issuance of a proposed rule, the requirements of the Regulatory 
    Flexibility Act (RFA) (5 U.S.C. 601 et seq.) do not apply. 
    Nevertheless, the Agency has previously assessed whether establishing 
    tolerances, exemptions from tolerances, raising tolerance levels or 
    expanding exemptions might adversely impact small entities and 
    concluded, as a generic matter, that there is no adverse economic 
    impact. The factual basis for the Agency's generic certification for 
    tolerance actions published on May 4, 1981 (46 FR 24950) and was 
    provided to the Chief Counsel for Advocacy of the Small Business 
    Administration.
    
    VIII. Submission to Congress and the Comptroller General
    
        The Congressional Review Act, 5 U.S.C. 801 et seq., as added by the 
    Small Business Regulatory Enforcement Fairness Act of 1996, generally 
    provides that before a rule may take effect, the Agency promulgating 
    the rule must submit a rule report, which includes a copy of the rule, 
    to each House of the Congress and to the Comptroller General of the 
    United States. EPA will submit a report containing this rule and other 
    required information to the U.S. Senate, the U.S. House of 
    Representatives, and the Comptroller General of the United States prior 
    to publication of this rule in the Federal Register. This rule is not a 
    ``major rule'' as defined by 5 U.S.C. 804(2).
    
    List of Subjects in 40 CFR Part 180
    
        Environmental protection, Administrative practice and procedure, 
    Agricultural commodities, Pesticides and pests, Reporting and 
    recordkeeping requirements.
    
        Dated: March 12, 1998.
    
    James Jones,
    Director, Registration Division, Office of Pesticide Programs.
        Therefore, 40 CFR chapter I is amended as follows:
    
    PART 180-- [AMENDED]
    
        1. The authority citation for part 180 continues to read as 
    follows:
    
        Authority: 21 U.S.C. 346a and 371.
    
        2. Section 180.1195 is added to read as follows:
    
    
    Sec. 180.1195  Titanium dioxide; exemption from the requirement of a 
    tolerance.
    
        Titanium dioxide is exempted from the requirement of a tolerance 
    for residues in or on growing crops, when used as an inert ingredient 
    (UV protectant) in microencapsulated formulations of the insecticide 
    lambda-cyhalothrin at no more than 3.0% by weight of the formulation.
    
    [FR Doc. 98-7492 Filed 3-24-98; 8:45 am]
    BILLING CODE 6560-50-F
    
    
    

Document Information

Effective Date:
3/25/1998
Published:
03/25/1998
Department:
Environmental Protection Agency
Entry Type:
Rule
Action:
Final rule.
Document Number:
98-7492
Dates:
This regulation is effective March 25, 1998. Objections and requests for hearings must be received by EPA on or before April 24, 1998.
Pages:
14360-14363 (4 pages)
Docket Numbers:
OPP-300632, FRL-5779-3
RINs:
2070-AB78
PDF File:
98-7492.pdf
CFR: (1)
40 CFR 180.1195